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Abstract: In synaptosomal brain membranes, the addition 
of oleic acid (cis), elaidic acid (trans), and the cis and trans 
isomers of vaccenic acid, at a concentration of 0.87 pmol of 
lipid/mg of protein, strongly reduced the B,, and, to a lesser 
degree, the binding affinity of the p-selective opioid [3H]Tyr- 
D-Ala-Gly-(Me)Phe-Gly-ol ( [3H]DAMGO). At comparable 
membrane content, the cis isomers of the fatty acids were 
more potent than their trans counterparts in inhibiting ligand 
binding and in decreasing membrane microviscosity, both at 
the membrane surface and in the core. However, trans-vac- 
cenic acid affected opioid receptor binding in spite of just 
marginally altering membrane microviscosity. If the receptors 
were uncoupled from guanine nucleotide regulatory protein, 
an altered inhibition profile was obtained: the impairment 
of KD by the fatty acids was enhanced and that of B,, re- 
duced. Receptor interaction of the 6-opioid [3H](D-Pen2,D- 
Pen5)enkephalin was modulated by lipids to a greater extent 
than that of [3H]DAMGO: saturable binding was abolished 
by both oleic and elaidic acids. The binding of [3H]naltrexone 
was less susceptible to inhibition by the fatty acids, particularly 
in the presence of sodium. In the absence of this cation, how- 
ever, cis-vaccenic acid abolished the low-affinity binding 
component of [3H]naltrexone. These findings support the 
membrane model of opioid receptor sequestration depicting 
different ionic environments for the p- and &binding sites. 
The results of this work show distinct modulation of different 
types and molecular states of opioid receptor by fatty acids 
through mechanisms involving membrane fluidity and spe- 
cific interactions with membrane constituents. Key Words: 
p- and 6-opioid receptors-Ligand-receptor interaction-Cis 
and trans fatty acids-Membrane lipid content-Membrane 
microviscosity. Remmers A. E. et al. Modulation of opioid 
receptor binding by cis and trans fatty acids. J. Neurochem. 
55, 1993-2000 (1 990). 
Analogous to the dependence of soluble enzymes on 
the composition and characteristics of their aqueous 
milieu, the activity of functional membrane proteins 
is influenced by properties of the lipid bilayer (Car- 
ruthers and Melchior, 1986). The function of surface 
receptors was shown to be modulated by the physical 
property of the membrane: for example, coupling to 
adenylate cyclase of the @-adrenergic receptor, but not 
of adenosine receptor, in turkey erythrocytes was en- 
hanced by decreasing membrane microviscosity (Ri- 
mon et al., 1978). On the other hand, in these cells, 
incorporated phosphatidylinositol uncoupled cate- 
cholamine binding from adenylate cyclase by a mech- 
anism other than membrane fluidity (McOsker et al., 
1983). The sensitivity of opioid receptors to lipids has 
been well documented. Ligand binding (Lin and Si- 
mon, 1978; Abood et al., 1980) and receptor coupling 
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to adenylate cyclase (Law et al., 1983) and low-K, 
GTPase (Lazar and Medzihradsky, 1990) were inhib- 
ited by phospholipase treatment, and unsaturated fatty 
acids decreased opioid receptor binding in cultured 
NG 108- 15 cells (Ho and Cox, 1982; McGee and Ken- 
imer, 1982). Acidic phospholipids containing poly- 
unsaturated fatty acids enhanced ligand binding to the 
partially purified p-opioid receptor (Hasegawa et al., 
1987), whereas phospholipids inhibited opioid receptor 
binding in rat brain membranes (Remmers and Med- 
zihradsky, 1987). 
Exogenous fatty acids were shown to alter mem- 
brane structure and function (e.g., Stubbs and Smith, 
1984), thereby exhibiting stereospecificity (Orly and 
Schramm, 1975; Seifert et al., 1988). In accord with 
our goal to characterize the modulation of opioid re- 
ceptors by membrane lipids (Medzihradsky, 1989), we 
Abbreviations used: DAMGO, Tyr-DAla-Gly-(Me)Phe-Gly-ol; 
DPH, diphenylhexatriene; DPDPE, (~-Pen~,~Pen’)enkephalin; G 
protein, guanine nucleotide regulatory protein; GLC, gas-liquid 
chromatography; GTP-y-S, guanosine 5’-0-(3-thiotnphosphate); 
TMA-DPH, trimethylammonium derivative of diphenylhexatriene. 
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now report the use of cis and trans fatty acids to discern 
mechanisms by which these compounds affect opioid 
ligand binding. The results show that the fatty acids 
inhibited opioid receptor binding in proportion to their 
membrane fluidizing property, but also acted by direct 
interaction with the phospholipid bilayer. The effect 
was different at the p- and &receptors, and was influ- 
enced by receptor conformation and state of coupling 
to  G protein. 
MATERIALS AND METHODS 
Materials 
Tritiated Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) and 
(D-Pen2,D-PenS)enkephalin (DPDPE) were purchased from 
Amersham (Arlington Heights, IL, U.S.A.) and New England 
Nuclear (Boston, MA, U.S.A.), respectively. [3H]Naltrexone 
was generously provided by the National Institute on Drug 
Abuse. DPDPE was a gift from Dr. H. I. Mosberg. DAMGO 
was purchased from Peninsula Laboratories (Belmont, CA, 
U.S.A.), and naltrexone was supplied by the Drug Abuse Basic 
Research Center at the University of Michigan. cis-9-Octa- 
decenoic acid (oleic acid), trans-9-octadecenoic acid (elaidic 
acid), and cis- and trans- 1 1-octadecenoic acids (vaccenic ac- 
ids) were obtained from Sigma (St. Louis, MO, U.S.A.). Di- 
phenylhexatriene (DPH) and its charged trimethylammo- 
nium derivative (TMA-DPH) were purchased from Molec- 
ular Probes (Junction City, OR, U.S.A.). Fatty acid methyl 
ester standards were purchased from Serdary Laboratories 
(London, Ontario, Canada) and Alltech (Deerfield, IL, 
U.S.A.). The gas-liquid chromatography (GLC) packing Silar 
10-C on 100/120 mesh Gas Chrom-I1 was obtained from 
Alltech, and BF3-methanol reagent was bought from Pierce 
(Rockford, IL, U.S.A.). 
Membrane preparation 
A crude synaptosomal preparation was isolated from cor- 
tices of male Sprague-Dawley rats weighing 180-200 g as 
described (Cahill and Medzihradsky, 1976). Briefly, cerebral 
cortices were dissected free of white matter at 4°C and ho- 
mogenized in 0.32 Msucrose at a concentration of 10% (wt/ 
vol). Tissue disruption was carried out at 500 rpm in a Potter- 
Elvehjem homogenizer with a Teflon pestle. The supernatant 
resulting from the centrifugation at 1,000 g for 10 rnin was 
centrifuged again at 15,000 g for 20 min. The upper part of 
the pellet, consisting of a fluffy light beige layer, was resus- 
pended in 50 mM Tris, pH 7.4. The suspension was centri- 
fuged at 15,000 g for 20 rnin to remove any remaining sucrose, 
resuspended in 50 mM Tris-HC1, pH 7.4, at a protein con- 
centration of approximately 1 mg/ml, and stored at -70°C. 
Determination of protein 
The methods according to Lowry et al. (195 1) and Bradford 
(1976) were used, with bovine serum albumin as a standard. 
In both procedures, the membrane protein was solubilized 
initially with 1 M NaOH for 30 rnin at 25°C. 
Measurement of membrane microviscosity 
The fluorescent probes DPH (solution in N,N-dimethyl- 
formamide) and TMA-DPH (solution in tetrahydrofuran) 
were incubated with membranes at 25°C for 30 rnin and 60 
min, respectively (Shinitzky and Barenholz, 1978; Kuhry et 
al., 1983). The molar ratio of probe to membrane phospho- 
lipid was approximately 1500. Subsequently, fluorescence 
polarization was measured in an SLM spectrofluorometer at 
wavelengths of 360 nm and 430 nm (DPH) and 340 nm and 
450 nm (TMA-DPH) for excitation and emission, respec- 
tively. 
Membrane modification with fatty acids 
The fatty acids were added to membrane suspensions in 
the form of an ethanol solution at a maximal alcohol con- 
centration of 0.4%. In control experiments, membranes were 
incubated with ethanol alone. Following incubation for 20 
min at 25"C, the membranes were centrifuged through 0.5 
M sucrose, pH 7.4, at 100,000 g for 20 rnin to remove sticking 
lipid. Membrane lipids were extracted with chloroform/ 
methanol (2: 1) according to Radin ( 1  969). Methylation of 
fatty acids was carried out using 14% BF3 in methanol as 
described (Morrison and Smith, 1964). The methyl esters 
were quantitated by GLC in a Hewlett-Packard 402B gas 
chromatograph with a flame ionization detector (Lazar and 
Medzihradsky, unpublished observations). The column (6 ft 
X in 0.d.) was packed with 10% Silar 10-C and operated 
with linear programming from 180°C at 2"C/min using ni- 
trogen as the carrier gas. The peak heights were quantitated 
using standards of fatty acid methyl esters. 
Ligand binding 
Ligand binding was carried out at 25°C as described (Fis- 
chel and Medzihradsky, 1981) in the absence and presence 
of 5 pM guanosine 5'-0-( 3-thiotriphosphate) (GTP-7-S) or 
150 mM NaCI. These concentrations of the nucleotide and 
sodium were shown in our study to affect maximally opioid 
agonist and antagonist binding, respectively. Specific binding 
of the radiolabeled opioids was determined in the absence 
and presence of an excess of the respective unlabeled ligand. 
These concentrations were 2 pA4 for [3H]DAMG0, 5 pMfor 
[3H]DPDPE, and 1 pLM for [3H]naltrexone. Binding equilib- 
rium was established at 80 min, 60 min, and 30 rnin for 
radiolabeled DAMGO, DPDPE, and naltrexone, respectively. 
The binding selectivity of the ligands was determined pre- 
viously (Clark et al., 1988). 
Statistical analysis of the data 
For the analysis of ligand binding, the NONLIN module 
in the SYSTAT statistical program (Wilkinson, 1988) was 
used. It is a generalized nonlinear least squares regression 
program that was applied to fit a two-site binding model. In 
some experiments, only a one-site model could be supported 
by the data. Data sets from three to five replicate experiments 
were combined to improve the regression analysis by increas- 
ing variability. Because a valid regression depends upon nor- 
mally distributed within-set random errors, the between-set 
errors were assigned to additional regression parameters that 
represented each of the replicate experiments. The weighed 
residual sum of squares thus reflected random experimental 
error. 
Following the initial regression, the residuals were displayed 
in a normal probability plot, using the GRAPH module, to 
evaluate both their magnitude and their departure from ex- 
pected, normally distributed residuals. All data reported are 
based upon regressions for which the distribution of residuals 
was not different from a normal distribution. The corre- 
sponding standard error of the mean was computed within 
NONLIN from the residual sum of squares of the regression. 
The hypothesis that two parameters are equal for different 
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FIG. 1. Membrane microviscosity and fatty acid content. A: Syn- 
aptosomal brain membranes were modified by the addition of 0.87 
pmol of fatty acid/mg of protein. Following lipid extraction, methyl 
esters of fatty acids were formed and analyzed by GLC as de- 
scribed under Materials and Methods. Shown are the mean mem- 
brane contents of fatty acids (+SD) obtained in three to four ex- 
periments. B Following incorporation of DPH and TMA-DPH into 
control and fatty acid-modified membranes, their fluorescence po- 
larization was determined. The results are expressed as anisotropy 
values (r) where r = (lo - + 2/90), and lo and IW represent 
the intensities of light when polarizers were in a parallel or per- 
pendicular orientation, respectively. Differences in the efficiency of 
transmitting vertically and horizontally polarized light were corrected 
for by determining the polarization ratio (lollW) using horizontally 
rather than vertically polarized excitation light. The advantage of 
expressing fluorescence polarization as anisotropy is the additive 
nature of the latter. Shown are the means k SD of four experiments, 
each carried out in quadruplicate. The results of these two series 
of experiments were subjected to a one-way analysis of variance 
as described under Materials and Methods. CON, control; EL, 
elaidic acid; OL, oleic acid; V or VAC, vaccenic acid. 
membrane treatments was tested by the usual statistic using 
the parameter mean and the standard error of the mean (see 
legends to Tables 1 and 2). 
The data on membrane microviscosity and membrane 
content of fatty acids were analyzed by the ANOVA module, 
a true one-way least squares analysis of variance in the 
SYSTAT statistical software program (Wilkinson, 1988). 
When a significant fatty acid effect was identified by the AN- 
OVA analysis, painvise contrasts were made to identify spe- 
cifically which fatty acid treatment effects were significant. 
Grouped contrasts, such as the combined cis versus trans 
fatty acid effects, were also tested by contrast options within 
ANOVA. 
RESULTS 
In initial experiments, the incorporation of the four 
fatty acids into brain membranes and their effect on 
membrane microviscosity were determined. At 0.87 
pmol of added lipid/mg of membrane protein, a con- 
centration causing substantial inhibition of opioid 
binding (see Fig. 2), the incremental membrane content 
of these compounds corresponded to approximately 
39% of the added fatty acid (Fig. IA). There was no 
significant difference in the incorporation of oleic and 
elaidic acids, but the membrane content of cis-vaccenic 
acid was 3% lower than its trans counterpart. Despite 
this difference, cis-vaccenic acid was more potent in 
modulating opioid receptor binding. Microviscosity in 
the hydrophobic membrane core (assessed by DPH) 
was strongly decreased by cis fatty acids and marginally 
by the trans isomers (Fig. 1B). Within the cis series, 
vaccenic acid reduced microviscosity to a greater ex- 
tent. At the membrane surface (assessed by the cation 
TMA-DPH), the lipid-induced changes in microvis- 
cosity were smaller, and the difference in respective 
potencies between cis and trans fatty acids was dimin- 
ished. This was particularly the case for oleic and elaidic 
acids, which displayed similar membrane fluidizing 
properties (Fig. IB). 
Determined at a single [ 3H]DAMG0 concentration 
of 10 X KD , all the fatty acids decreased specific binding 
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FIG. 2. Inhibition of specific [3H]DAMG0 binding by fatty acids. 
Membranes were treated with cis- (0) and trans- (0) vaccenic acids 
(A) or oleic (0) and elaidic (0) acids (B), as described under Materials 
and Methods. Subsequently, the specific binding of 4 nM 
[3H]DAMG0 at equilibrium was determined. Results are expressed 
as percent of control binding. Ethanol added to control membranes 
up to 0.5% did not affect ligand binding. insets: The inhibition of 
[3H]DAMG0 binding is plotted against the log concentration of 
fatty acids. The respective ECS0 values (in pmollmg of membrane 
protein) were as follows: cis-vaccenic, 0.71 ; trans-vaccenic, 1.37; 
oleic, 0.55, elaidic, 0.79. Shown are mean values of three exper- 
iments carried out in duplicate. 
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isomers were more effective than their trans counter- 
parts: the ECso values (in pmol/mg of protein) for cis- 
and trans-vaccenic acid were 0.71 and 1.37, and for 
oleic and elaidic acids 0.55 and 0.79, respectively (Fig. 
2, insets). In accord with its significant effect on mem- 
brane surface microviscosity, elaidic acid strongly in- 
hibited opioid receptor binding. Thus, in contrasting 
the effects of cis and trans fatty acids, there was a pos- 
itive correlation between decreased binding and re- 
duced microviscosity, particularly when the latter was 
measured at the membrane surface. This relationship 
was highlighted by the limited effect of trans-vaccenic 
acid in altering microviscosity and ligand binding (Fig. 
2A and Table 1). 
The effect of lipids on ligand binding was evaluated 
further by nonlinear regression analysis. The binding 
of the p-selective opioid [3H]DAMG0 in unmodified 
membranes revealed one population of saturable sites 
with a KD of 0.4 nM and a B,, of 151 fmol/mg of 
protein in the absence of GTP-y-S, and values of 1.4 
nM and 152 fmol/mg of protein in the presence of the 
nucleotide (Table 1). Following treatment, both the 
affinity and capacity of binding were reduced (Fig. 3). 
Oleic and elaidic acids were more effective than the 
vaccenic acids in reducing B,, and increasing KD val- 
ues. Of particular interest is the fact that these param- 
eters were affected differentially by fatty acid modu- 
lation of the uncoupled receptor obtained in the pres- 
ence of GTP-y-S (Fig. 4A and Table 1): whereas the 
rise in KD values was enhanced, the decrease in B,, 
values was diminished. 
In the presence of GTP-y-S, [3H]DPDPE binding 
was characterized by one population of saturable sites 
with KD and B,,, values of 2.7 n M  and 45 fmol/mg 
of protein, respectively (Table 1). Both pairs of fatty 
acid isomers strongly reduced the affinity and extent 
of binding of this 6-ligand (Fig. 4B and Table 1). Their 
effect was much more pronounced than at the p-site: 
oleic and elaidic acids totally suppressed the specific 
binding of [3H]DPDPE. As with p-opioid binding, cis- 
vaccenic acid affected both the KD and B,, values of 
ligand binding, whereas trans-vaccenic acid primarily 
decreased the binding affinity of [3H]DPDPE (Table 1). 
In the absence and presence of sodium, the binding 
of [3H]naltrexone revealed two populations of saturable 
binding sites (Fig. 5 and Table 2). We have observed 
recently that in rat brain membranes this heterogeneity 
reflects interaction with p- and 6-opioid receptors; in 
the presence of p- or &selective opioids, [3H]naltrexone 
binding was monophasic with only the low- or high- 
affinity component, respectively, remaining (Remmers 
and Medzihradsky, unpublished observations). Similar 
findings were obtained previously with the nonselective 
opioid antagonist [3H]diprenorphine in guinea pig 
TABLE 1. Parameters of agonist binding 
B,, 
KD (fmol/mg of protein) n 
Fatty acid 
added" -GTP-7-S +GTP-7-S -GTP-r-S +GTP-7-S -GTP-y-S +GTP-r-S 
['HIDAMGO 
None 0.41 1.43 150.93 151.98 76 101 
cis-Vaccenic 0.66 7.5 1 70.45 98.15 33 39 
trans-Vaccenic 0.45 4.38 1 1  1.98 157.05 30 45 
Oleic 1.65 10.11 49.7 1 63.76 28 52 
Elaidic 0.83 8.29 67.06 79.87 27 46 
(0.01) (0.05) (0.84) (1.33) 
(0.03) (0.49) (1.21) (2.92) 
(0.02) (0.18) (1.10) (2.24) 
(0.15) ( I  .03) (2.17) (3.1 1) 
(0.05) (0.50) (1.61) (2.30) 
['HIDPDPE 
None 2.66 44.7 1 78 
cis-Vaccenic 13.32 8.90 37 
trans-Vaccenic 16.03 35.76 48 
Oleic ND ND 28 
Elaidic ND ND 25 
The binding parameters at equilibrium were obtained from nonlinear regression analysis using a receptor model with one or two binding 
sites. Shown are parameter means and the standard error of the means (in parentheses) computed from the total number, n, of data points 
obtained in three to five experiments, as described under Materials and Methods. All the values listed in this table are different from the 
respective controls at the 5% level of significance. The experiments were carried out in the absence (-) and presence (+) of 5 pM GTP-7-S. 
ND, saturable binding not detected. 
Membrane modification was carried out as described under Materials and Methods. The fatty acids were added at the concentration of 
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FIG. 3. Scatchard plots of [3H]DAMG0 binding. Membranes were 
treated with fatty acids, added at a concentration of 0.87 pmol/ 
mg of membrane protein, as described under Materials and Meth- 
ods. Subsequently, the equilibrium binding of PHIDAMGO in control 
membranes (A) and membranes modified with cis- (0) and trans- 
(0) vaccenic acid (A) or oleic (0) and elaidic (0) acids (B) was 
determined. Plotted are data points from a representative exper- 
iment. The binding parameters, KD and B,,, from three to five 
experiments, were obtained by nonlinear regression analysis and 
are listed together with statistical information in Table 1. 
brain membranes; in the presence of the &selective 
opioid ICI 174,864, its binding was monophasic and 
p-specific (Werling et al., 1988). Compared to their in- 
hibition of opioid agonist binding, the fatty acids were 
less effective in altering the binding of [3H]naltrexone, 
particularly in the presence of NaCl. Whereas all bind- 
ing parameters of [3H]DAMG0 and [3H]DPDPE were 
different following fatty acid treatment (Table l), only 
two of these constants for [3H]naltrexone were signif- 
icantly different from controls (Table 2). However, in 
the absence of sodium, cis-vaccenic acid selectively 
abolished the low-affinity binding component of 
[3H]naltrexone, while limiting its effect at the high-af- 
finity site to an increased KD value (Table 2). 
DISCUSSION 
As shown by their numerous acute and chronic ef- 
fects, fatty acids modulate manifold membrane func- 
tions (e.g., Stubbs and Smith, 1984). A possible com- 
mon mechanism by which these diverse compounds 
may act involves their ability to alter membrane flu- 
idity. In producing this effect, the potency of a fatty 
acid is generally proportional to the degree of unsat- 
uration and number of cis double bonds in the mole- 
cule. In addition to this general mode of action, struc- 
tural elements of membrane lipids have been shown 
to modulate the activity of intrinsic proteins in a spe- 
cific manner (Carruthers and Melchior, 1988). Despite 
extensive evidence for the correlation of membrane 
fluidity and physiological activity, including membrane 
function (e.g., U t e s  and Manson, 1984; Aloia et al., 
1988), a role of this membrane property as a primary 
molecular phenomenon has rarely been demonstrated. 
Chronic treatment of neural cells with free fatty acids 
appreciably reduced the binding capacity of opioid li- 
gands (Ho and Cox, 1982; McGee and Kenimer, 1982). 
The extent of these effects correlated with the degree 
of fatty acid unsaturation. Although the involvement 
of membrane fluidity was postulated, it was not assessed 
experimentally. 
In the present work, we have used two pairs of fatty 
acid enantiomers of different chemical structure, but 
with the same degree of unsaturation, to study the 
mechanisms by which these compounds influence li- 
gand-receptor interactions. Throughout the study, the 
cis fatty acids, at comparable membrane content, were 
more potent than the transisomers in decreasing mi- 
croviscosity and in reducing the binding affinity and 
B,, of [3H]DAMG0. In the trans series, elaidic acid 
with a relatively strong fluidizing effect at the mem- 
brane surface inhibited ligand binding to a greater ex- 
tent than did trans-vaccenic acid. On the other hand, 
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FIG. 4. Equilibrium binding of 13H]DAMG0 (A) and r3H]DPDPE (6) 
in the presence of GTP-y-S. Membranes were treated with fatty 
acids, added at a concentration of 0.87 pmollmg of membrane 
protein, as described under Materials and Methods. Subsequently, 
equilibrium binding of [3H]DAMG0 (A) and [3H]DPDPE (B) in the 
presence of 5 pM GTP-y-S was determined in control membranes 
(A) and membranes modified with oleic (0) and elaidic (@) acids. 
Shown are data points from three to six experiments. The binding 
parameters and statistical information, obtained by nonlinear 
regression analysis as described under Materials and Methods, 
are listed in Table 1. 
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FIG. 5. Scatchard plots of [3H]naltrexone binding. Membranes 
were treated with fatty acids, added at a concentration of 0.87 
pmollmg of membrane protein, as described under Materials and 
Methods. Subsequently, the equilibrium binding of [3H]naltrexone 
in the absence (A) and presence (B) of 150 mM NaCl was deter- 
mined in control membranes (A) and membranes modified with 
cis- (0) and trans- (0) vaccenic acid. Shown are the results from 
a representative experiment. The binding parameters and statistical 
data are listed in Table 2. 
viscosity, trans-vaccenic acid still impaired opioid re- 
ceptor binding. This observation indicates either that 
fatty acids also act by a mechanism separate from that 
involving membrane fluidity, or that the small change 
in microviscosity (Fig. 1 B) does not reflect a more pro- 
nounced effect in the vicinity of the receptor. The lim- 
iting resolution of the applied fluorescence technique 
prevents us from excluding localized changes in mem- 
brane microviscosity resulting from the partitioning of 
the fatty acids, including the trans isomers, into discrete 
domains of the lipid bilayer (Karnovsky et al., 1982). 
One membrane area of primary importance for recep- 
tor function is the lipid-protein interface. The assess- 
ment of microviscosity in this boundary layer, in con- 
trast to the analysis of bulk fluidity, should reveal the 
intimate relationship between this membrane property 
and opioid receptor mechanisms. Such experiments 
are in preparation. In this regard, it is of interest that 
the determination of microviscosity at the membrane 
surface with the cationic probe TMA-DPH disclosed 
a fluidizing property of elaidic acid not observed 
with DPH. 
The responses of opioid receptor to lipid modulation 
were altered following its uncoupling from G protein 
by GTP-7-S treatment. In general, the free receptor 
was more susceptible to fatty acid actions. A specific 
lipid requirement for the activation of G, by the p- 
adrenergic receptor in erythrocyte membranes has been 
reported (Ben-Arie et al., 1988), and the inhibition of 
opioid receptor coupling to brain GTPase by phos- 
pholipase A2 was described (Lazar and Medzihradsky, 
1990). Although these observations indicate a function 
for lipids in receptor-effector coupling, mechanistic 
conclusions are difficult to reach, considering the loss 
of bilayer sidedness during membrane isolation. An 
approach to assess differentially the role of lipids at the 
membrane surfaces and in its core has been described 
recently (Medzihradsky, 1989). 
The finding that fatty acids affected (although with 
TABLE 2. Parameters of antagonist binding 
Bmax I B m u 2  
Fatty acid' NaCl KDI KD2 (nw (fmol/mg of protein) (fmol/mg of protein) n 
[ 'HINaltrexone 
0.38 None - 
(0.07) 
3.06 cis-Vaccenic - 
(0.14) 
0.56 trans-Vaccenic - 
(0.09) 
None + 0.39 
(0.03) 
cis-Vaccenic + 0.40 
(0.04) 




































The binding parameters at equilibrium were obtained from nonlinear regression analysis using a receptor model with one or two binding 
sites, as described under Materials and Methods. Shown are parameter means and the standard error of the means (in parentheses) computed 
from the total number, n, of data points obtained in three to five experiments, as described under Materials and Methods. ND, saturable binding 
not detected. 
Membrane modification was camed out as described under Materials and Methods. The fatty acids were added at the concentration of 
0.87 pmollmg of membrane protein. 
The assay medium in some experiments contained 150 mM NaCl (+) and in all experiments 5 f iA4 GTP-7-S. 
' Value is different from control at the 5% level of significance. 
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considerable quantitative differences) the opioid re- 
ceptor in its free and coupled states (Table l), as well 
as its agonist or antagonist conformation (Table 2), 
suggests that the inhibitory action of these compounds 
involves a general perturbation of the lipid bilayer, re- 
sulting in altered membrane microviscosity. As shown, 
hydrogen bond formation between the fatty acid car- 
boxyl group and phosphate residues in the phospho- 
lipid matrix results in diminished repulsion of the 
charged head groups in the bilayer (Ortiz and Gomez- 
Fernandez, 1987). In addition, because of stenc hin- 
drance, the cis isomers disturb the lipid packing density 
and, thus, strongly affect membrane microviscosity. A 
reciprocal relationship between decreasing membrane 
microviscosity and availability of ligand binding sites 
for some receptors, including serotonergic, P-adren- 
ergic, and opioid, was interpreted by the concept of 
vertical displacement of membrane proteins (Shinitzky, 
1984). It is reasonable to expect that altered receptor 
positioning in the membrane would affect, in addition 
to B,,,, access of the ligand to the binding site and, 
thus, KD. The differentiated profile of fatty acid action, 
e.g., preferential inhibition of opioid agonist binding 
and higher potency of the cis acids, ruled out receptor 
solubilization by detergent-like effects as the underlying 
mechanism. Furthermore, even at fatty acid concen- 
trations twofold higher than those used in the experi- 
ments, no loss in membrane protein was observed. It 
was shown previously that bovine serum albumin can 
reverse the inhibitory action of endogenously generated 
(phospholipase-catalyzed), but not added, fatty acids 
(Lin and Simon, 1978). 
Considering a sequestration of opioid receptors in 
the membrane (Schwyzer, 1986) and the putative role 
of membrane in modulating receptor-ligand association 
(Sargent and Schwyzer, 1986), perturbations of this 
microenvironment by the fatty acid-lipid interactions 
outlined above are likely to selectively influence opioid 
ligand binding. Support for this postulate was provided 
by our results with the p- and &selective opioids 
DAMGO and DPDPE (Clark et al., 1988), and the 
nonselective antagonist naltrexone (Gillan et al., 1980). 
In contrast to the milder effects on the preceptor, the 
fatty acid treatment of membranes virtually eliminated 
the saturable binding of [3H]DPDPE. Because the p- 
and &receptors are apparently localized in an anionic 
and cationic membrane environment, respectively 
(Sargent et al., 1988; Schiller et al., 1989), the carboxyl 
groups of the fatty acids should interact preferentially 
with that microenvironment of the lipid bilayer con- 
taining the binding sites for t3H]DPDPE. Furthermore, 
by influencing the degree of ionization of the carboxyl 
groups, the local pH could thereby have a modulating 
role (Hauser et al., 1979). In this respect, it is of interest 
to note the differential effect of fatty acids on the two 
binding components of [3H]naltrexone. Considering 
the observations that low-affinity binding of this an- 
tagonist (Remmers and Medzihradsky, unpublished 
observations) reflects its interaction with the 6-opioid 
receptor, the effect of cis-vaccenic acid (Table 2) could 
reflect the preferential targeting of the &receptor by 
fatty acid action also observed with agonist binding 
(Fig. 4 and Table 1). The molecular reasons for the 
preferential inhibition by fatty acids of agonist binding 
and for the protective effect of NaCl against inhibition 
of antagonist binding are presently unclear. 
It is plausible to suggest that the modulation of 
opioid receptors by fatty acids reported herein may 
have a physiological role in the action of opioids. 
Changes in circulating fatty acid profiles induced by 
diet, aging, or pathophysiological developments may 
alter the interaction of opioid receptors with their en- 
dogenous opioids and, thus, affect the manifold pro- 
cesses involving these compounds. As shown in this 
study, depending on the fatty acid profile, a differen- 
tiated response in opioid receptor function can be ex- 
pected. Cellular regulation by unsaturated fatty acids 
has been proposed on the basis of their stimulation of 
calcium-dependent protein kinase (McPhail et al., 
1984) and direct activation of potassium channels 
(Ordway et al., 1989). 
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